Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Outcomes of Post-transplant Percutaneous Portal Vein Interventions: A Single Pediatric Liver Transplantation Center Experience.

Created on 17 Jun 2025

Authors

Gaia Messana, Roberto Miraglia, Luigi Maruzzelli, Davide Coppolino, Mariapina Milazzo, Roberta Gerasia, Diletta Donà, Keid Bici, Davide Cintorino, Jean de Ville de Goyet

Published in

Cardiovascular and interventional radiology. Jun 16, 2025. Epub Jun 16, 2025.

Abstract

To evaluate the long-term results of transhepatic treatment of portal vein complications (PVCs) after pediatric liver transplantation (PLTx) at a single center.
All interventional procedures for PVCs after PLTx performed between 2005 and 2023 were retrospectively analyzed. Clinical signs of portal hypertension and portal vein (PV) flow velocity on Doppler ultrasound were routinely assessed during follow-up. Primary patency, assisted primary patency, and survival rates were evaluated.
Out of 275 consecutive PLTs, 26 children (median age 19.8 months, range: 8.5-154.1) underwent 39 endovascular procedures for PVCs. Technical success was achieved in 97% of procedures. The median time interval between PLTx and the procedure was 5.4 months (range: 0.27-57.1). Percutaneous transluminal angioplasty (PTA) was performed in 81%, stenting in 15%, and thrombolysis in 4% of cases as the primary intervention. A significant decrease in the median trans-stenotic pressure gradient from 9 mmHg (range 4-22) to 1 mmHg (range 0-10) (p < 0.001) was observed. Recurrent stenosis was observed in 31% of patients. Two procedural complications occurred, both managed conservatively. Primary patency rates at 6 months, 1, 3, 5, and 10 years were 74%, 68%, 65%, 54%, 54%, respectively. Assisted primary patency remained 100%. The patient survival rate was 96% at all intervals. The median follow-up time was 60.47 months (range 2.2-174.3).
PTA should be the preferred first-line treatment for PV stenosis in PLTx recipients, with stenting reserved for refractory cases. PTA is applicable for selected cases of PV thrombosis. Regular surveillance and timely interventions ensure favorable long-term outcomes.

PMID:
40524033
Bibliographic data and abstract were imported from PubMed on 17 Jun 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 24
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement